Drug Search Results

Eliprodil

Alternative Names: eliprodil
Latest Update: 2023-12-20
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Institute of Neurological Disorders and Stroke (NINDS)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Eliprodil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Parkinson's Disease|Movement Disorders

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
99-N-0078	P2	Completed	Parkinson's Disease\|Movement Disorders	None

Recent News Events

Date	Type	Title
12/20/2023	PubMed	Characterization of (R)- and (S)-[18F]OF-NB1 in Rodents as Positron Emission Tomography Probes for Imaging GluN2B Subunit-Containing N-Methyl-d-Aspartate Receptors.
07/05/2022	PubMed	Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.
02/28/2022	PubMed	Gram-Scale Synthesis of (R)-P-Chlorophenyl-1,2-Ethanediol at High Concentration by a Pair of Epoxide Hydrolases.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions